セッション詳細
[O7]Oral 7 Ovary/ POI-1
2025年4月27日(日) 16:20 〜 17:14
Hall D5
Chair(s): Kazuhiro Kawamura (Japan), Yuki Enomoto (Japan)
[O7-1]WDR24 mutations contributes to premature ovarian insufficiency
○Ting Guo, Bingying Xu, Yingying Qin (State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University)
[O7-2]Explore the potential role of α-SNAP in follicle activation and development through PI3K/Akt/mTORC1 signaling pathway
○Ying Qin, Yali Song, Yan Sun, Xiaoqing Luo, Haiping Wen, Qianxia Lin, Jing Cai, Daidi Mo, Wenyao Lai (Reproductive Medicine Center, Dongguan Maternal and Child Health Care Hospital)
[O7-3]Sigma-1 receptor-mediated high mobility group A1 silencing alleviates endoplasmic reticulum stress-induced ovarian granulosa cell apoptosis
○Lile Jiang1,2,3, Shujun Yang1 2, Cuilian Zhang1 2 3 (1.Reproductive Medical Center, People’s Hospital of Provincial People’s Hospital, 2.Reproductive Medical Center, People’s Hospital of Zhengzhou University, 3.Reproductive Medical Center, People’s Hospital of Henan University)
[O7-4]Interaction between host and graft-derived ovarian tissue in mouse model of chemotherapy-Induced ovarian insufficiency
○Mahiru Kawano1,2, Jennifer McKey2 3, Mina Sakata1, Gaku Yamamoto1, Yuka Ikenaga1, Aasa Shimizu1, Yasuto Kinose1, Michiko Kodama1, Kenjiro Sawada1, Blanche Capel2 (1.Department of Obstetrics and Gynecology,, The University of Osaka, 2.Department of Cell Biology, Duke University Medical Center, 3.Department of Pediatrics, University of Colorado)
[O7-5]HELQ maintains genome stability of primordial germ cells by inhibiting LINE-1 expression
○Yajuan Yang1,2,3,4,5,6,7, Lili Cao1 2 3 4 5 6 7, Jiayi Ren1 2 3 4 5 6 7, Yingying Qin1 2 3 4 5 6 7, Zi-Jiang Chen1 2 3 4 5 6 7 8 9, Shidou Zhao1 2 3 4 5 6 7 (1.State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, 2.National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, 3.Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, 4.Shandong Technology Innovation Center for Reproductive Health, 5.Shandong Provincial Clinical Research Center for Reproductive Health, 6.Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, 7.Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No.2021RU001), 8.Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, 9.Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine)
[O7-6]Improving ovarian function by utilizing a Zeolitic Imidazolate Framework-8 (ZIF8) loaded growth hormone targeted release system
○Shan Wang1,2, Shao Yang2, Yawei Sun1, Wei Luo1 2, Mengru Yu1 2 (1.Department of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 2.Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University)